Literature DB >> 27255751

Sub-synaptic localization of Cav3.1 T-type calcium channels in the thalamus of normal and parkinsonian monkeys.

Erdong Chen1,2, Jean-Francois Paré1,2, Thomas Wichmann1,2,3, Yoland Smith4,5,6.   

Abstract

T-type calcium channels (Cav3) are key mediators of thalamic bursting activity, but also regulate single cells excitability, dendritic integration, synaptic strength and transmitter release. These functions are strongly influenced by the subcellular and subsynaptic localization of Cav3 channels along the somatodendritic domain of thalamic cells. In Parkinson's disease, T-type calcium channels dysfunction in the basal ganglia-receiving thalamic nuclei likely contributes to pathological thalamic bursting activity. In this study, we analyzed the cellular, subcellular, and subsynaptic localization of the Cav3.1 channel in the ventral anterior (VA) and centromedian/parafascicular (CM/Pf) thalamic nuclei, the main thalamic targets of basal ganglia output, in normal and parkinsonian monkeys. All thalamic nuclei displayed strong Cav3.1 neuropil immunoreactivity, although the intensity of immunolabeling in CM/Pf was significantly lower than in VA. Ultrastructurally, 70-80 % of the Cav3.1-immunoreactive structures were dendritic shafts. Using immunogold labeling, Cav3.1 was commonly found perisynaptic to asymmetric and symmetric axo-dendritic synapses, suggesting a role of Cav3.1 in regulating excitatory and inhibitory neurotransmission. Significant labeling was also found at non-synaptic sites along the plasma membrane of thalamic neurons. There was no difference in the overall pattern and intensity of immunostaining between normal and parkinsonian monkeys, suggesting that the increased rebound bursting in the parkinsonian state is not driven by changes in Cav3.1 expression. Thus, T-type calcium channels are located to subserve neuronal bursting, but also regulate glutamatergic and non-glutamatergic transmission along the whole somatodendritic domain of basal ganglia-receiving neurons of the primate thalamus.

Entities:  

Keywords:  Centromedian; Immunogold; MPTP; Parafascicular; Parkinson’s disease; Primate

Mesh:

Substances:

Year:  2016        PMID: 27255751      PMCID: PMC5135628          DOI: 10.1007/s00429-016-1242-9

Source DB:  PubMed          Journal:  Brain Struct Funct        ISSN: 1863-2653            Impact factor:   3.270


  125 in total

Review 1.  Towards the discovery of novel T-type calcium channel blockers.

Authors:  Philippe Lory; Jean Chemin
Journal:  Expert Opin Ther Targets       Date:  2007-05       Impact factor: 6.902

Review 2.  Low-threshold calcium currents in central nervous system neurons.

Authors:  J R Huguenard
Journal:  Annu Rev Physiol       Date:  1996       Impact factor: 19.318

3.  Visualization of calcium influx through channels that shape the burst and tonic firing modes of thalamic relay cells.

Authors:  Q Zhou; D W Godwin; D M O'Malley; P R Adams
Journal:  J Neurophysiol       Date:  1997-05       Impact factor: 2.714

4.  Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.

Authors:  Gunasingh J Masilamoni; James W Bogenpohl; David Alagille; Kristen Delevich; Gilles Tamagnan; John R Votaw; Thomas Wichmann; Yoland Smith
Journal:  Brain       Date:  2011-07       Impact factor: 13.501

Review 5.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

6.  Calcium transients in dendrites of neocortical neurons evoked by single subthreshold excitatory postsynaptic potentials via low-voltage-activated calcium channels.

Authors:  H Markram; B Sakmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

7.  Electrophysiology of mammalian thalamic neurones in vitro.

Authors:  R Llinás; H Jahnsen
Journal:  Nature       Date:  1982-06-03       Impact factor: 49.962

8.  Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: ultrastructural localization and electrophysiological effects of activation in the striatopallidal complex.

Authors:  James Bogenpohl; Adriana Galvan; Xing Hu; Thomas Wichmann; Yoland Smith
Journal:  Neuropharmacology       Date:  2012-05-23       Impact factor: 5.250

9.  The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism.

Authors:  H Bergman; T Wichmann; B Karmon; M R DeLong
Journal:  J Neurophysiol       Date:  1994-08       Impact factor: 2.714

10.  Anatomical localization of Cav3.1 calcium channels and electrophysiological effects of T-type calcium channel blockade in the motor thalamus of MPTP-treated monkeys.

Authors:  Annaelle Devergnas; Erdong Chen; Yuxian Ma; Ikuma Hamada; Damien Pittard; Stefan Kammermeier; Ariana P Mullin; Victor Faundez; Craig W Lindsley; Carrie Jones; Yoland Smith; Thomas Wichmann
Journal:  J Neurophysiol       Date:  2015-11-04       Impact factor: 2.714

View more
  2 in total

1.  In-vivo diffusion MRI protocol optimization for the chimpanzee brain and examination of aging effects on the primate optic nerve at 3T.

Authors:  Xiaodong Zhang; Chun-Xia Li; Yumei Yan; Govind Nair; James K Rilling; James G Herndon; Todd M Preuss; Xiaoping Hu; Longchuan Li
Journal:  Magn Reson Imaging       Date:  2020-12-23       Impact factor: 2.546

2.  Effects of alfaxalone on cerebral blood flow and intrinsic neural activity of rhesus monkeys: A comparison study with ketamine.

Authors:  Chun-Xia Li; Doty Kempf; Leonard Howell; Xiaodong Zhang
Journal:  Magn Reson Imaging       Date:  2020-10-27       Impact factor: 2.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.